|
Real-time Estimate
Cboe BZX
20:21:37 02/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.710 USD | -9.51% |
|
+9.28% | -59.76% |
| 09-04 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 08-12 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 28.88M | - | - | - | - | - |
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
- Stock Market
- Stocks
- NXTC Stock
- Charts NextCure, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
